A Randomized, Double-blind, Placebo ‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Condition:   Extensive Stage Small Cell Lung Cancer Interventions:   Drug: HLX10;   Drug: carboplatin and etoposide;   Drug: placebo Sponsor:   Shanghai Henlius Biotech Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials